Archives

Clinical Trials

ADD & ADHD

Alzheimer's Disease

Anxiety

○ Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.


○ Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.


○ Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.


○ Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation.


○ Effects of cannabidiol (CBD) on regional cerebral blood flow


○ The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors.


○ The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.


○ Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.


○ A Systematic Review of Plant-Derived Natural Compounds for Anxiety Disorders.


○ The Endocannabinoid System and Anxiety.


○ Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders.


○ Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats.


○ Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report.


○ Cannabidiol Does Not Dampen Responses to Emotional Stimuli in Healthy Adults.

Depression


Inflammation

○ Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.


○ The endocannabinoid system: an emerging key player in inflammation.


○ Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice.


○ Cannabinoids, endocannabinoids, and related analogs in inflammation.


○ Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor.


○ Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.


○ Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis.


○ Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation.


○ Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement.


○ Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.


○ Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation.


○ Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death.


○ Cannabinoids in clinical practice.


○ Cannabinoids, inflammation, and fibrosis.


○ Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain.


○ Protective effect of cannabidiol on hydrogen peroxide‑induced apoptosis, inflammation and oxidative stress in nucleus pulposus cells.


○ Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis.

Pain

Stress

This section doesn’t currently include any content. Add content to this section using the sidebar.